US00130H1059 - Common Stock - After market: 26.97 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2022-11-29 | UBS | Maintains | Buy |
2022-11-11 | Morgan Stanley | Maintains | Overweight |
2022-11-09 | Citigroup | Maintains | Buy |
2022-10-21 | Morgan Stanley | Maintains | Overweight |
2022-10-19 | Credit Suisse | Maintains | Neutral |
2022-10-04 | Goldman Sachs | Maintains | Buy |
2022-08-18 | Morgan Stanley | Maintains | Overweight |
2022-07-21 | Morgan Stanley | Maintains | Overweight |
2022-06-23 | Morgan Stanley | Maintains | Overweight |
2022-06-13 | Morgan Stanley | Maintains | Overweight |
2022-04-26 | Credit Suisse | Initiate | Neutral |
2022-04-20 | Morgan Stanley | Maintains | Overweight |
2022-01-06 | Morgan Stanley | Maintains | Overweight |
2021-11-30 | Goldman Sachs | Initiate | Buy |
2021-11-02 | Morgan Stanley | Maintains | Overweight |
2021-08-19 | Morgan Stanley | Maintains | Overweight |
2021-08-06 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
2021-07-29 | Morgan Stanley | Maintains | Overweight |
2021-06-21 | Susquehanna | Initiate | Positive |
2021-05-18 | Morgan Stanley | Maintains | Overweight |
2021-05-04 | Morgan Stanley | Maintains | Overweight |
2021-03-19 | Morgan Stanley | Maintains | Overweight |
2021-03-10 | Morgan Stanley | Maintains | Overweight |
Find the competitors with the best analyst ratings on the USA